Login
Toggle navigation
Videos
Categories
Trending
Maxime Séché is the Chief Executive Officer of Séché Environnement, a leading environmental services company.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joël Séché, Président Fondateur de Séché Environnement.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Embracing Philotimo: The Power of Values and Community Leadership | Michael G. Psaros, Co-Founder, KPS Capital Partners.
00:10:00
Advancing Neurosurgical Procedures with Innovative MRI-Compatible Technology |Joseph M. Burnett, CEO, ClearPoint Neuro Inc.
00:10:00
Azimut's Strategic Vision | Paolo Martini, CEO , Azimut Holding.
00:10:00
Sarama Resources' Strategic Plans and Investment Potential in 2020: Insights from the CEO at Cape Town Mining Conference
00:10:00
Economic and Market Outlook for 2024: Insights from Russell Investments
00:10:00
Unlocking the Deep Sea: Developing the World's Largest Battery Metal Resource
00:10:00
fundamentally transform the way people work|Lan Xuezhao, Managing Partner,Basis Set Ventures
00:10:00
Closing international deals, analyst reports, stock price targets, & more | Andre Larente, CEO, Diagnos IncADK:CVE
00:10:00
Getty Realty Corp diversifies Strategy into Convenience and Automotive Retail|CHRISTOPHER J. CONSTANT,President and CEO, Getty Realty Corp
00:10:00
Pioneering Lithium Exploration: ION Energy's Journey in Mongolia
00:10:00
Discussing Autism and Innovation with Dr. Simon Baron-Cohen.|Simon Baron-Cohen,Professor,Cambridge University
00:10:00
Equitas SFB's PN Vasudevan Discusses the Future of Small Finance Banks and Key Insights on India's Banking Evolution | PN Vasudevan ,CEO , Equitas Small Finance Bank Ltd..